| Factor Information | |
|---|---|
| Data ID | 1301 |
| Factor | Haemoglobin |
| Description | haemoglobin levels were significantly higher in patients who experienced cardiac complications (p≤0.01). |
| Biomarker | NA |
| Classification | E2 (physiological factor - biochemical index) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | severe cardiac events |
| p Value | 0.01 |
| Conclusion | Outcome of pregnancy in women with PAH-CHD is better than previously reported, with only 5% maternal mortality in our cohort. However, because of the severity of heart failure and the high rate of neonatal complications, patients should still be advised against pregnancy |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 514 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | VSD/PA, VSD/ASD/PDA/DORV, AC/TA/AVSD/SV/ccTGA, VSD |
| Reference | |
|---|---|
| PMID | 27511447 |
| Year | 2017 |
| Title | Pregnancy outcomes in patients with pulmonary arterial hypertension associated with congenital heart disease. |
| Sample | ||
|---|---|---|
| Population | Pregnancy | |
| Source | N/A | |
| Region | France | |
| Method | N/A | |
| Race | Europe | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | Cardiac complications(Treatment) | No complication(Control) |
| Number | 6 | 12 |
| Age | 29±6 years | 28±6 years |
| Gender (Male: Female) | 0:6 | 0:12 |
| Marker Level | 19.4±0.8 g/dL | 16.1±0.8 g/dL |
